Washington, DC ― Sarah Ferris reports in The Hill that the U.S. Senate’s Health, Education, Labor and Pensions (HELP) Committee on Tuesday announced that it will not take up a major House-passed biomedical research package known as 21st Century Cures, dealing a major blow to leaders in the lower chamber.
HELP Committee Chairman Lamar Alexander (R-Tennessee) said Tuesday that members will vote separately on bills ranging from neurological diseases research to electronic medical records.
HELP Committee Chairman Lamar Alexander (R-Tennessee) said Tuesday that members will vote separately on bills ranging from neurological diseases research to electronic medical records.
The Senate’s strategy for passing bipartisan biomedical research legislation is a far cry from the House, where the Energy and Commerce Committee spent more than a year working on a final package. That legislation overwhelmingly passed on July 10, 2015.
Chairman Alexander announced that the HELP Committee will hold its first executive session considering bills on biomedical innovation on Tuesday, February 9. At that committee meeting, the committee will consider at least seven bipartisan bills.
The committee’s February meeting will be the first of three. The two meetings held in March and April will consider additional bipartisan bills.
Ferris reported that the Senate committee’s bills—which will include both President Obama’s “precision medicine” initiative as well as Vice President Biden’s cancer-research “moonshot” bid—are likely to draw controversy from at least some Republicans.
For Ferris’ Hill story, click here.
Chairman Alexander announced that the HELP Committee will hold its first executive session considering bills on biomedical innovation on Tuesday, February 9. At that committee meeting, the committee will consider at least seven bipartisan bills.
The committee’s February meeting will be the first of three. The two meetings held in March and April will consider additional bipartisan bills.
Ferris reported that the Senate committee’s bills—which will include both President Obama’s “precision medicine” initiative as well as Vice President Biden’s cancer-research “moonshot” bid—are likely to draw controversy from at least some Republicans.
For Ferris’ Hill story, click here.
